(Q41590964)

4 October 2017

title

Thrombolytic eligibility in acute myocardial infarction patients admitted to Norwegian hospitals (English)

1 reference

4 October 2017

1 reference

Reikvam A

1

1 reference

4 October 2017

Ketley D

series ordinal

2

1 reference

4 October 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

International Journal of Cardiology

4 October 2017

published in

1 reference

4 October 2017

volume

61

1 reference

4 October 2017

issue

1

1 reference

4 October 2017

page(s)

79-83

1 reference

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900132-0

7 January 2021

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900132-0

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900132-0

7 January 2021

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900132-0

7 January 2021

Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900132-0

7 January 2021

Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900132-0

7 January 2021

Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment. The GREAT Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900132-0

7 January 2021

Deciding who should have thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900132-0

7 January 2021

Thrombolytic therapy for acute myocardial infarction in older patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900132-0

7 January 2021

Thrombolytic treatment for elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900132-0

7 January 2021

10.1016/S0167-5273(97)00132-0

Identifiers

DOI

1 reference

4 October 2017

1 reference